Display options
Cite
Lorusso D, Mancini M, Di Rocco R, et al. The role of secondary surgery in recurrent ovarian cancer. Int J Surg Oncol. 2012;2012:613980doi: 10.1155/2012/613980.
Lorusso, D., Mancini, M., Di Rocco, R., Fontanelli, R., & Raspagliesi, F. (2012). The role of secondary surgery in recurrent ovarian cancer. International journal of surgical oncology, 2012613980. https://doi.org/10.1155/2012/613980
Lorusso, D, et al. "The role of secondary surgery in recurrent ovarian cancer." International journal of surgical oncology vol. 2012 (2012): 613980. doi: https://doi.org/10.1155/2012/613980
Lorusso D, Mancini M, Di Rocco R, Fontanelli R, Raspagliesi F. The role of secondary surgery in recurrent ovarian cancer. Int J Surg Oncol. 2012;2012:613980. doi: 10.1155/2012/613980. Epub 2012 Aug 05. PMID: 22919475; PMCID: PMC3420128.
Copy Download .nbib Format: NLM
Share it on

Int J Surg Oncol. 2012;2012:613980. doi: 10.1155/2012/613980. Epub 2012 Aug 05.

The role of secondary surgery in recurrent ovarian cancer.

International journal of surgical oncology

D Lorusso, M Mancini, R Di Rocco, R Fontanelli, F Raspagliesi

Affiliations

  1. Fondazione IRCCS Istituto Nazionale Tumori, Via Venezian 1, 20133 Milan, Italy.

PMID: 22919475 PMCID: PMC3420128 DOI: 10.1155/2012/613980

Abstract

Despite optimal treatment (complete cytoreduction and adjuvant chemotherapy), 5-year survival for advanced ovarian cancer is approximately 30% and most patients succumb to their disease. Cytoreductive surgery is accepted as a major treatment of primary ovarian cancer but its role in recurrent disease is controversial and remains a field of discussion mainly owing to missing data from prospective randomized trials. A critical review of literature evidence on secondary surgery in recurrent ovarian cancer will be described.

References

  1. Eur J Obstet Gynecol Reprod Biol. 1999 Oct;86(2):185-8 - PubMed
  2. Ann Surg. 2009 Jun;249(6):900-7 - PubMed
  3. Eur J Obstet Gynecol Reprod Biol. 2008 Oct;140(2):263-8 - PubMed
  4. Cancer. 2000 Jan 1;88(1):144-53 - PubMed
  5. J Clin Oncol. 2006 Aug 20;24(24):4011-9 - PubMed
  6. Gynecol Oncol. 1989 Apr;33(1):1-5 - PubMed
  7. Lancet. 2003 Jun 21;361(9375):2099-106 - PubMed
  8. J Clin Oncol. 2005 Aug 20;23(24):5605-12 - PubMed
  9. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727-33 - PubMed
  10. J Clin Oncol. 2006 Oct 10;24(29):4699-707 - PubMed
  11. Gynecol Oncol. 2005 Apr;97(1):74-9 - PubMed
  12. Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007822 - PubMed
  13. Eur J Surg Oncol. 2010 Jun;36(6):589-93 - PubMed
  14. Obstet Gynecol. 1983 Feb;61(2):189-93 - PubMed
  15. Cancer. 1992 Oct 15;70(8):2129-36 - PubMed
  16. Gynecol Oncol. 2010 May;117(2):336-40 - PubMed
  17. J Clin Oncol. 2003 Oct 15;21(20):3737-43 - PubMed
  18. Int J Gynaecol Obstet. 2003 Oct;83 Suppl 1:135-66 - PubMed
  19. Gynecol Oncol. 1994 Dec;55(3 Pt 2):S138-42 - PubMed
  20. Gynecol Oncol. 2001 May;81(2):237-41 - PubMed
  21. Br J Cancer. 2005 Mar 28;92(6):1026-32 - PubMed
  22. Ann Surg Oncol. 2006 Dec;13(12):1702-10 - PubMed
  23. Ann Surg Oncol. 2007 Feb;14(2):484-92 - PubMed
  24. Ann Oncol. 2007 May;18(5):827-34 - PubMed
  25. Eur J Surg Oncol. 1989 Jun;15(3):201-4 - PubMed
  26. Gynecol Oncol. 1995 Apr;57(1):61-5 - PubMed
  27. Am J Obstet Gynecol. 2006 Jan;194(1):49-56 - PubMed
  28. Gynecol Oncol. 2009 Jan;112(1):265-74 - PubMed
  29. Cancer. 2004 Mar 15;100(6):1152-61 - PubMed
  30. Int J Gynecol Cancer. 2005 Nov-Dec;15 Suppl 3:195-8 - PubMed
  31. J Clin Oncol. 1993 Mar;11(3):434-9 - PubMed
  32. Lancet. 2010 Oct 2;376(9747):1155-63 - PubMed
  33. Obstet Gynecol. 2002 Jun;99(6):1008-13 - PubMed
  34. Ann Surg Oncol. 2007 Mar;14(3):1136-42 - PubMed
  35. Gynecol Oncol. 2000 Dec;79(3):344-9 - PubMed
  36. Ann Surg Oncol. 2009 May;16(5):1324-30 - PubMed
  37. Curr Opin Oncol. 2005 Sep;17(5):505-14 - PubMed
  38. Int J Gynecol Cancer. 1995 Nov;5(6):449-458 - PubMed

Publication Types